- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04291794
Mean Arterial Pressure Reduction Anesthesia Induction Using Propofol Bolus or Tritiated Target-infusion
February 28, 2020 updated by: Gabriel Magalhaes Nunes Guimaraes, Brasilia University Hospital
Mean Arterial Pressure Reduction During the First Ten Minutes After General Anesthesia Induction Using Propofol Bolus or Tritiated Target-infusion: Superiority Randomized Controlled Trial
To compare haemodynamics and bispectral index values between conventional bolus propofol induction and target-controlled propofol infusion.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
To compare mean arterial pressure, heart rate and bispectral index values between conventional bolus propofol induction and target-controlled propofol infusion.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Gabriel MN Guimaraes, MSc
- Phone Number: +5561996455997
- Email: gabrielmng@gmail.com
Study Locations
-
-
Distrito Federal
-
Brasilia, Distrito Federal, Brazil, 70000000
- Hospital Universitário de Brasília
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Scheduled for general anesthesia;
- No contraindication for propofol.
Exclusion Criteria:
- Data loss;
- Protocol violation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional bolus induction
Hypnotic component of general anesthesia induction will be a single bolus of propofol 2mg/kg followed by turning on sevoflurane 2% at a fresh gas flow of 2L/min.
|
2mg/kg single bolus
|
Experimental: Target-controlled induction
Hypnotic component of general anesthesia induction will be target-controlled propofol infusion tritiated to loss of consciousness.
Propofol target-controlled infusion will be maintained.
|
Tritiated Target-Controlled Infusion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean arterial pressure after 2 minutes
Time Frame: 2 minutes after general anesthesia induction
|
Mean arterial pressure using non-invasive device
|
2 minutes after general anesthesia induction
|
Mean arterial pressure after 4 minutes
Time Frame: 4 minutes after general anesthesia induction minutes after general anesthesia induction
|
Mean arterial pressure using non-invasive device
|
4 minutes after general anesthesia induction minutes after general anesthesia induction
|
Mean arterial pressure after 6 minutes
Time Frame: 6 minutes after general anesthesia induction minutes after general anesthesia induction
|
Mean arterial pressure using non-invasive device
|
6 minutes after general anesthesia induction minutes after general anesthesia induction
|
Mean arterial pressure after 8 minutes
Time Frame: 8 minutes after general anesthesia induction minutes after general anesthesia induction
|
Mean arterial pressure using non-invasive device
|
8 minutes after general anesthesia induction minutes after general anesthesia induction
|
Mean arterial pressure after 10 minutes
Time Frame: 10 minutes after general anesthesia induction minutes after general anesthesia induction
|
Mean arterial pressure using non-invasive device
|
10 minutes after general anesthesia induction minutes after general anesthesia induction
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart Rate after 2 minutes
Time Frame: 2 minutes after general anesthesia induction
|
Heart rate (pulse rate) using non-invasive device.
|
2 minutes after general anesthesia induction
|
Heart Rate after 4 minutes
Time Frame: 4 minutes after general anesthesia induction
|
Heart rate (pulse rate) using non-invasive device.
|
4 minutes after general anesthesia induction
|
Heart Rate after 6 minutes
Time Frame: 6 minutes after general anesthesia induction
|
Heart rate (pulse rate) using non-invasive device.
|
6 minutes after general anesthesia induction
|
Heart Rate after 8 minutes
Time Frame: 8 minutes after general anesthesia induction
|
Heart rate (pulse rate) using non-invasive device.
|
8 minutes after general anesthesia induction
|
Heart Rate after 10 minutes
Time Frame: 10 minutes after general anesthesia induction
|
Heart rate (pulse rate) using non-invasive device.
|
10 minutes after general anesthesia induction
|
Bispectral Index after 2 minutes
Time Frame: 2 minutes after general anesthesia induction
|
Bispectral Index (BIS) using non-invasive device.
At values near 100 mean patient is more likely to be awake and at values below 60 are more likely to be under general anesthesia.
|
2 minutes after general anesthesia induction
|
Bispectral Index after 4 minutes
Time Frame: 4 minutes after general anesthesia induction
|
Bispectral Index (BIS) using non-invasive device.
At values near 100 mean patient is more likely to be awake and at values below 60 are more likely to be under general anesthesia.
|
4 minutes after general anesthesia induction
|
Bispectral Index after 6 minutes
Time Frame: 6 minutes after general anesthesia induction
|
Bispectral Index (BIS) using non-invasive device.
At values near 100 mean patient is more likely to be awake and at values below 60 are more likely to be under general anesthesia.
|
6 minutes after general anesthesia induction
|
Bispectral Index after 8 minutes
Time Frame: 8 minutes after general anesthesia induction
|
Bispectral Index (BIS) using non-invasive device.
At values near 100 mean patient is more likely to be awake and at values below 60 are more likely to be under general anesthesia.
|
8 minutes after general anesthesia induction
|
Bispectral Index after 10 minutes
Time Frame: 10 minutes after general anesthesia induction
|
Bispectral Index (BIS) using non-invasive device.
At values near 100 mean patient is more likely to be awake and at values below 60 are more likely to be under general anesthesia.
|
10 minutes after general anesthesia induction
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2020
Primary Completion (Anticipated)
September 25, 2020
Study Completion (Anticipated)
November 27, 2020
Study Registration Dates
First Submitted
February 26, 2020
First Submitted That Met QC Criteria
February 28, 2020
First Posted (Actual)
March 2, 2020
Study Record Updates
Last Update Posted (Actual)
March 2, 2020
Last Update Submitted That Met QC Criteria
February 28, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- tccgui2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
Plan to share at open database.
IPD Sharing Time Frame
After study ends
IPD Sharing Access Criteria
Open
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypotension on Induction
-
University Medical Center Ho Chi Minh City (UMC)RecruitingHypotension on InductionVietnam
-
Kangbuk Samsung HospitalNot yet recruitingHypotension on Induction
-
Taipei Medical UniversityNational Science Council, TaiwanActive, not recruitingHypotension on InductionTaiwan
-
Cairo UniversityCompletedHypotension on InductionEgypt
-
Zoll Medical CorporationThe Cleveland ClinicWithdrawn
-
Cairo UniversityCompletedHypotension on InductionEgypt
-
Mount Sinai Hospital, CanadaNot yet recruitingHypotension on InductionCanada
-
Cairo UniversityRecruitingHypotension on InductionEgypt
-
Min SuRecruiting
-
University of ToledoRecruitingHypotension on InductionUnited States
Clinical Trials on Propofol
-
Hopital FochCompleted
-
Konkuk University Medical CenterCompletedCoronary Artery Disease | Valvular Heart DiseaseKorea, Republic of
-
University Medical Center GroningenCompletedAnesthesia | Hemodynamic Instability | Interaction | Disorder of Oxygen TransportNetherlands
-
Asan Medical CenterCompletedPopulation Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy VolunteersHealthyKorea, Republic of
-
Tiva GroupMedtronic - MITGCompleted
-
Pontificia Universidad Catolica de ChileCompletedSurgery | Anesthesia | Depth of Anesthesia | NeonateChile
-
Mansoura UniversityCompleted
-
KVG Medical College and HospitalUnknown
-
Acibadem UniversityCompleted